All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. The role of biomarkers in ruling out cerebral lesions in mild cranial trauma

    KCE Reports 261 (2016)

    https://kce.fgov.be/en/the-role-of-biomarkers-in-ruling-out-cerebral-lesions-in-mild-cranial-trauma

  2. Left ventricular assist devices in the treatment of end-stage heart failure

    KCE Reports 264 (2016)

    https://kce.fgov.be/en/left-ventricular-assist-devices-in-the-treatment-of-end-stage-heart-failure

  3. Use of pneumococcal vaccines in the elderly: an economic evaluation

    KCE Reports 274 (2016) Supplementary material pdf fileR274_Supplementary-file_Univariate-sensitivity-analyses (13.95 MB) pdf fileR274_Supplementary-file_Sensitivity-analyses_PPV23-price (1.1 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_Net-benefit-Box-plots (1.16 MB) pdf fileR274_Supplementary-file_Multivariate-sensitivity-analyses_CEAFs-and-CE-planes (58.74 MB) The results are also available in a searchable spreadsheet-database format for all scenario and sensitivity analyses.

    https://kce.fgov.be/en/use-of-pneumococcal-vaccines-in-the-elderly-an-economic-evaluation

  4. Elective caesarean section in low-risk women at term: consequences for mother and offspring

    KCE Reports 275 (2016)

    https://kce.fgov.be/en/elective-caesarean-section-in-low-risk-women-at-term-consequences-for-mother-and-offspring

  5. Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

    KCE Reports 276 (2016)

    https://kce.fgov.be/en/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for-chronic-hepatitis